NIDA has reissued its Program Announcements (PAs) soliciting collaborative research proposals between investigators from domestic U.S. institutions and researchers in other countries. The PAs—International Research Collaboration on Drug Abuse and Addiction Research—will be in effect until May 8, 2018. Researchers may choose one of three grant programs in response to these broad calls for innovative research proposals:
- R01: PA-15-142
- R21: PA-15-143
- R03: PA-15-141.
Applications are encouraged in all areas of NIDA-supported science, including basic laboratory studies, clinical studies, epidemiological studies, community-based studies, and services research. Research priority areas include:
- Acute and chronic effects of marijuana, especially on the neurobiology and function of the brain, and the impacts of policies and laws regarding marijuana possession and use
- Linkages between HIV and drug use, especially seek, test, treat, and retain strategies to reach and test high-risk individuals and initiate and monitor highly active antiretroviral therapy for those who test positive
- The nature and extent of amphetamine-type stimulant abuse and synthetic and other designer drug abuse, their short- and long-term consequences, and prevention and treatment approaches
- Inhalant abuse, including epidemiological data, development and implementation of effective prevention programs, neurobiological impacts, and public awareness initiatives
- Prenatal impact of smoking and the effects on young people and adolescents of early exposure to tobacco, especially on cognitive development, progression to addiction, and development of other diseases
- Testing technologies to assess the prevalence of driving under the influence of drugs, the role of drugs in accidents, and the costs and benefits of laws and other programs to reduce the incidence and impact of drugged driving.